30/07/2026
Cancer treatment is evolving rapidly—but every new study, drug or combination must be interpreted in the context of the individual patient.
At ASCO Direct™ 2026, Mysuru, Dr. Sunit Lokwani participated in focused scientific discussions on emerging oncology evidence, treatment sequencing, patient selection, safety, monitoring and real-world clinical application.
Modern oncology is not only about knowing what is new. It is about understanding:
Which patient may benefit
Where a treatment fits in the overall sequence
How side effects should be anticipated and monitored
Whether the expected benefit is meaningful for that specific clinical situation
Because the same cancer diagnosis may still require different decisions based on stage, biopsy, pathology, biomarkers, previous treatment, organ function, overall condition and treatment goals.
Evidence guides the options. Clinical evaluation shapes the plan.
Dr. Sunit Lokwani
Medical Oncologist | Clinical Hematologist
Siya Health Care, Indore
📞 +91 78985 11151
For report-based consultation and second opinion.
Treatment decisions depend on clinical evaluation, diagnosis, stage, reports, biomarkers and patient condition. This content is for awareness and does not replace medical consultation.